Internal Reference Number: FOI_6723
Date Request Received: 04/08/2022 00:00:00
Date Request Replied To: 31/08/2022 00:00:00
This response was sent via: By Email
Request Summary: Dermatological conditions
Request Category: Companies
| Question Number 1: How many patients were treated in last 4 months by the Dermatology department (for any disease) with each of the following: • Abrocitinib • Acitretin • Alitretinoin • Azathioprine • Baricitinib • Ciclosporin • Dupilumab • Methotrexate • Mycophenolate mofetil • Pimecrolimus • Tacrolimus ointment • Tralokinumab • Upadacitinib | |
| Answer To Question 1: Abrocitinib 0 Acitretin 29 Alitretinoin 5 Azathioprine <5 Baricitinib 0 Ciclosporin 6 Dupilumab 14 Methotrexate 24 Mycophenolate <5 Pimecrolimus 11 Tacrolimus ointment 30 Tralokinumab 0 Upadacitinib 0 | |
| Question Number 2: Of the patients treated in the last 4 months with any of the products listed in Q1, how many patients were paediatric (age 17 or under)? | |
| Answer To Question 2: None. | |
| Question Number 3: How many patients were treated in the last 4 months with phototherapy (UVB or PUVA) for atopic dermatitis ONLY? | |
| Answer To Question 3: 0 patients were treated in the last 4 months with phototherapy for atopic dermatitis only. | |
| To return to the list of all the FOI requests please click here |
Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of ¾¨Ó㴫ý Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
